Celebrating our 10th anniversary – Unlock our special offer today

FDA expected to issue recommendation ‘soon’ on CBD regulation in the US

The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country.

In an interview with The Wall Street Journal, the agency’s deputy commissioner of food and drugs, Janet Woodcock, said that the FDA will address three citizen petitions it received about the safety of CBD in food products, which may clarify its position over the issue.

Read full article
I'm already a subscriber

Tiziana Cauli

Senior reporter
Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization